Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$0.357 0.0234 | 7.01%
07/25/16 - 03:59 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 4.84M 9.26M 2.51M 8.42M
Cost of Sales 355.00K 748.00K 2.30M 12.57M
Gross Operating Profit 4.48M 8.51M 207.00K -4.15M
Selling, General, and Administrative Expenses 10.52M 11.42M 13.55M 15.38M
Research & Development 14.65M 21.29M 5.12M 5.38M
Operating Income before D & A (EBITDA) -20.68M -24.20M -18.47M -24.90M
Depreciation & Amortization 567.00K 170.00K 327.00K 240.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 3.07M 2.23M 3.65M 425.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -18.18M -22.14M -15.14M -24.72M
Interest Expense 845.00K 339.00K 727.00K 325.00K
Pre-Tax Income -19.02M -22.48M -15.87M -25.04M
Income Taxes 0.00 0.00 0.00 516.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -19.02M -22.48M -15.87M -25.56M
Net Income From Discontinued Operations 0.00 691.00K -1.07M -6.21M
Net Income From Total Operations -19.02M -21.79M -16.94M -31.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -19.02M -21.79M -16.94M -31.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-19.02M -22.48M -15.87M -25.56M
Preferred Dividends
Net Income Available To Common -19.02M -22.48M -15.87M -25.56M
Basic EPS from Continuing Ops. -0.38 -0.57 -0.46 -0.93
Basic EPS from Discontinued Ops. 0.00 0.02 -0.03 -0.23
Basic EPS from Total Operations -0.38 -0.55 -0.49 -1.16
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.38 -0.55 -0.49 -1.16
Basic Normalized Net Income/Share -0.38 -0.57 -0.46 -0.93
EPS fr Continuing Ops. -0.38 -0.57 -0.46 -0.93
EPS fr Discontinued Ops 0.00 0.02 -0.03 -0.23
EPS fr Total Ops. -0.38 -0.55 -0.49 -1.16
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.57 0.00 0.00
EPS, Total -0.38 0.02 -0.49 -1.16
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.38 -0.57 -0.46 -0.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter